Literature DB >> 2393962

Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action.

S Y Lee1, H M Rhee.   

Abstract

In an effort to understand the mechanism of cardiovascular actions of Ganoderma lucidum which was cultivated in Korea, the mycelium was isolated for a large-scale culture. Water extract of the mycelia was evaluated for its cardiovascular activity in anesthetized rabbits and rats. The left femoral artery and vein were cannulated for the measurement of arterial pressure and subsequent delivery of drugs. The left kidney was exposed retroperitoneally and a branch of the renal nerve was used to integrate renal efferent or afferent nerve activities. The extract decreased systolic and diastolic blood pressure, which was accompanied by an inhibition of renal efferent sympathetic nerve activity. The extract did not decrease heart rate in these animals, although there was clear hypotension in the extract dose dependent manner. This suggests that the hypotension induced by the treatment of the extract was secondary to the primary effect of the extract in the central nerve system, which suppressed the sympathetic outflow. Therefore we concluded that the mechanism of hypotensive action of Ganoderma lucidum was due to its central inhibition of sympathetic nerve activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393962     DOI: 10.1248/cpb.38.1359

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  9 in total

1.  Apoptosis induction of colorectal cancer cells HTL-9 in vitro by the transformed products of soybean isoflavones by Ganoderma lucidum.

Authors:  Mei-Lin Cui; Huan-Yi Yang; Guo-Qing He
Journal:  J Zhejiang Univ Sci B       Date:  2017 Dec.       Impact factor: 3.066

2.  Analysis of triterpenoids in ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry.

Authors:  Min Yang; Xiaoming Wang; Shuhong Guan; Jiameng Xia; Jianghao Sun; Hui Guo; De-An Guo
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-26       Impact factor: 3.109

3.  Metabolism and pharmacokinetics in rats of ganoderiol F, a highly cytotoxic and antitumor triterpene from Ganoderma lucidum.

Authors:  Qun Zhang; Feng Zuo; Norio Nakamura; Chao-Mei Ma; Masao Hattori
Journal:  J Nat Med       Date:  2009-05-01       Impact factor: 2.343

4.  Induction of apoptosis in the SW620 colon carcinoma cell line by triterpene-enriched extracts from Ganoderma lucidum through activation of caspase-3.

Authors:  Zhe Ji; Qingjiu Tang; Ruixia Hao; Jinsong Zhang; Yingjie Pan
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

5.  In vitro and in vivo protective effects of proteoglycan isolated from mycelia of Ganoderma lucidum on carbon tetrachloride-induced liver injury.

Authors:  Xiao-Jun Yang; Jing Liu; Lin-Bai Ye; Fan Yang; Li Ye; Jin-Rong Gao; Zheng-Hui Wu
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

Review 6.  Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.

Authors:  Ulrike Grienke; Teresa Kaserer; Florian Pfluger; Christina E Mair; Thierry Langer; Daniela Schuster; Judith M Rollinger
Journal:  Phytochemistry       Date:  2014-11-06       Impact factor: 4.072

Review 7.  Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors.

Authors:  Nerida L Klupp; Dennis Chang; Fiona Hawke; Hosen Kiat; Huijuan Cao; Suzanne J Grant; Alan Bensoussan
Journal:  Cochrane Database Syst Rev       Date:  2015-02-17

8.  The genome of Ganoderma lucidum provides insights into triterpenes biosynthesis and wood degradation [corrected].

Authors:  Dongbo Liu; Jing Gong; Wenkui Dai; Xincong Kang; Zhuo Huang; Hong-Mei Zhang; Wei Liu; Le Liu; Junping Ma; Zhilan Xia; Yuxin Chen; Yuewen Chen; Depeng Wang; Peixiang Ni; An-Yuan Guo; Xingyao Xiong
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

9.  Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs.

Authors:  A Berger; D Rein; E Kratky; I Monnard; H Hajjaj; I Meirim; C Piguet-Welsch; J Hauser; K Mace; P Niederberger
Journal:  Lipids Health Dis       Date:  2004-02-18       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.